Sai Life Sciences Limited (SAILIFE.BO)
BSE · INR · Healthcare · Diagnostics & Research
₹1,484.15 (+2.73%) as of
Key statistics
- Market cap
- 315.34B
- P/E (TTM)
- 87.66
- Forward P/E
- 59.34
- EPS (TTM)
- 16.93
- Dividend yield
- 0.00%
- 52-week range
- 786.15 – 1,697.00
- Revenue (TTM)
- 22.5B
- Profit margin
- 16.08%
- Analyst target
- ₹1,562.29
- Volume
- 12.49k
About Sai Life Sciences Limited
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It offers medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is headquartered in Hyderabad, India.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Hyderabad, India
- Employees
- 5,224
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.